AIM
IPCI

Advantage Investment Management’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Advantage Investment Management’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-50
Closed -$1K – 917
2014
Q4 		$1K Buy
+50
New +$1.35K ﹤0.01% 769

Other funds holding IPCI

TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FMBTD
First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RCM
Rotella Capital Management Bellevue, Washington $1.47M AUM 12.32% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Advantage Investment Management's IPCI Position: Q1 2015 in Review

Advantage Investment Management sold out of Intellipharmaceuticals International Inc. (IPCI) in Q1 2015, closing a stake of 50 shares — an estimated $1K sold.

Advantage Investment Management first reported a position in IPCI in Q4 2014 and held it in 1 quarter. The position peaked at $1K in Q4 2014. 19 funds tracked by Wall St. Rank hold IPCI as of Q1 2015.

  • Advantage Investment Management reported no remaining Intellipharmaceuticals International Inc. position as of Q1 2015 after selling out during the quarter.
  • Advantage Investment Management sold 50 Intellipharmaceuticals International Inc. shares in Q1 2015, an estimated $1K.
  • Advantage Investment Management first reported a position in Intellipharmaceuticals International Inc. in Q4 2014 and held it in 1 quarter.
  • Advantage Investment Management's Intellipharmaceuticals International Inc. position peaked at $1K in Q4 2014.
  • 19 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q1 2015.

Based on Advantage Investment Management's 13F filing for Q1 2015, filed 27 Mar 2017.